Tag:
Elias Mosialos
Mosialos: The priority is to increase the number of people over 60 who have received a fourth dose
Given the fatigue citizens in many countries are feeling due to the constant vaccinations, we now need better vaccines. Unless...
ILL. Mosialos: insufficient scientific data for the administration of a 2nd booster dose in people aged 30-59
«The National Vaccination Committee has done important work during the pandemic. However, its current recommendation regarding...
Ilias Mosialos: What do we know about cases of hepatitis of unknown cause in children?
Claims linking the rise in hepatitis cases—the cause of which remains unclear at this time—to the COVID-19 vaccine are unfounded...
ILL. Mosialos: those who have made the third dose should not be particularly worried about Omicron
The spread of the new Omicron variant of the coronavirus means that we need to "get our third dose right away because, as...
Elias Mosialos on the vaccination of children 5-11 years old
The need for parents to set aside their hesitations and have their children ages 5 to 11 vaccinated...
ILL. Mosialos: Omicron variant appears to cause mild disease
New encouraging data from South Africa regarding the new African Omicron variant of the coronavirus, which until...
Coronavirus – African variant: The most significant to date, says Britain – Global alert
There is global alarm over the new coronavirus variant detected in Botswana, with the United Kingdom announcing that...
ILL. Mosialos: mRNA vaccines give strong immune response in patients with multiple sclerosis
Patients with multiple sclerosis (MS) who are being treated with ocrelizumab or rituximab (aCD20) are encouraged to...
I. Mosialos: The Johnson & Johnson vaccine provides 100% protection 28 days later
The Johnson & Johnson vaccine provides 100% protection against hospitalization due to COVID-19 and is not affected by the Brazilian...
Mosialos: what we know about the effectiveness of vaccines
The concerns that many people are expressing about the non-mRNA vaccines from AstraZeneca, Novavax, and Johnson & Johnson, regarding...
Coronavirus: Il. Mosialos presents a comparison table of seven vaccines
The Janssen/Johnson & Johnson vaccine announcement seemed to present a vaccine of moderate efficacy, but in fact it was...
Tough measures but without seeing sufficient data
By Sophia AnastasiouComplete lack of transparency and ambiguity, even in the release of data. Since the beginning of the coronavirus pandemic...